112 related articles for article (PubMed ID: 2428557)
21. Plasma levels of gastrointestinal regulatory peptides in patients receiving maintenance hemodialysis.
Hegbrant J; Thysell H; Ekman R
Scand J Gastroenterol; 1991 Jun; 26(6):599-604. PubMed ID: 1713707
[TBL] [Abstract][Full Text] [Related]
22. Activation of autonomic nerves and the adrenal medulla contributes to increased glucagon secretion during moderate insulin-induced hypoglycemia in women.
Havel PJ; Ahren B
Diabetes; 1997 May; 46(5):801-7. PubMed ID: 9133547
[TBL] [Abstract][Full Text] [Related]
23. Relationship between intravenous ethanol, alcohol-induced inhibition of pancreatic secretion and plasma concentration of immunoreactive pancreatic polypeptide, vasoactive intestinal peptide, and somatostatin in man.
Staub JL; Sarles H; Chayvialle JA; Descos F; Lassmann V; Vague P
Regul Pept; 1981 Apr; 2(1):61-8. PubMed ID: 6112782
[TBL] [Abstract][Full Text] [Related]
24. Meal stimulated levels of pancreatic polypeptide (PP) and vasoactive intestinal polypeptide (VIP) in gastroplasty for morbid obesity.
Miskowiak J; Andersen B; Stadil F; Fahrenkrug J
Regul Pept; 1985 Nov; 12(3):231-6. PubMed ID: 4081128
[TBL] [Abstract][Full Text] [Related]
25. Distribution of calcitonin-gene-related peptide, neuropeptide-Y, vasoactive intestinal polypeptide, cholecystokinin-8, substance P and islet peptides in the pancreas of normal and diabetic rats.
Adeghate E
Neuropeptides; 1999 Jun; 33(3):227-35. PubMed ID: 10657496
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular, metabolic, and hormonal responses to noradrenaline in diabetic patients with autonomic neuropathy.
Dejgaard A; Andersen P; Hvidberg A; Hilsted J
Diabet Med; 1996 Nov; 13(11):983-9. PubMed ID: 8946158
[TBL] [Abstract][Full Text] [Related]
27. The response of regulatory peptides to moderate hypoglycaemia of short duration in type 1 (insulin-dependent) diabetes mellitus and in normal man.
Tallroth G; Ryding E; Ekman R; Agardh CD
Diabetes Res; 1992; 20(3):73-85. PubMed ID: 1285360
[TBL] [Abstract][Full Text] [Related]
28. Prevention of glucose-induced hypotension by the somatostatin analogue octreotide (SMS 201-995) in chronic autonomic failure: haemodynamic and hormonal changes.
Raimbach SJ; Cortelli P; Kooner JS; Bannister R; Bloom SR; Mathias CJ
Clin Sci (Lond); 1989 Dec; 77(6):623-8. PubMed ID: 2691174
[TBL] [Abstract][Full Text] [Related]
29. Gut peptides in lactation.
Holst N; Jenssen TG; Burhol PG; Jorde R; Maltau JM; Haug E
Br J Obstet Gynaecol; 1986 Feb; 93(2):188-93. PubMed ID: 2868752
[TBL] [Abstract][Full Text] [Related]
30. Cholecystokinin and pancreatic polypeptide release in diabetic patients with and without autonomic neuropathy.
Glasbrenner B; Dominguez-Munoz E; Riepl RL; Vetsi A; Malfertheiner P
Dig Dis Sci; 1995 Feb; 40(2):406-11. PubMed ID: 7851207
[TBL] [Abstract][Full Text] [Related]
31. Cephalic phase of pancreatic polypeptide release: a valid test of autonomic neuropathy in diabetics?
Glasbrenner B; Bruckel J; Gritzmann R; Adler G
Diabetes Res Clin Pract; 1995 Nov; 30(2):117-23. PubMed ID: 8833632
[TBL] [Abstract][Full Text] [Related]
32. Effects of sham hemodialysis on plasma levels of vasoactive peptides in patients with uremia.
Hegbrant J; Mårtensson L; Thysell H; Ekman R; Boberg U
ASAIO J; 1992; 38(3):M197-200. PubMed ID: 1281014
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic polypeptide responses to hypoglycemia in chronic autonomic failure.
Polinsky RJ; Taylor IL; Chew P; Weise V; Kopin IJ
J Clin Endocrinol Metab; 1982 Jan; 54(1):48-52. PubMed ID: 7033270
[TBL] [Abstract][Full Text] [Related]
34. Diabetic autonomic neuropathy and impaired human pancreatic polypeptide secretion in response to food.
Lugari R; Gnudi A; Dall'Argine P; Vattini A; Rignanese G; Dall'Aglio B; Melchionda N; Colella P; Luciani A; Toscani S
J Clin Endocrinol Metab; 1987 Feb; 64(2):279-82. PubMed ID: 3793851
[TBL] [Abstract][Full Text] [Related]
35. Autonomic dysfunction in patients with chronic intestinal pseudo-obstruction.
Camilleri M; Balm RK; Low PA
Clin Auton Res; 1993 Apr; 3(2):95-100. PubMed ID: 8324379
[TBL] [Abstract][Full Text] [Related]
36. Impaired pancreatic polypeptide response to a meal in type 1 diabetic patients: vagal neuropathy or islet cell dysfunction?
Rasmussen MH; Carstensen H; List S; Schwartz TW; Hilsted J
Acta Endocrinol (Copenh); 1993 Mar; 128(3):221-4. PubMed ID: 8480470
[TBL] [Abstract][Full Text] [Related]
37. Apomorphine-induced nausea in humans: release of vasopressin and pancreatic polypeptide.
Feldman M; Samson WK; O'Dorisio TM
Gastroenterology; 1988 Sep; 95(3):721-6. PubMed ID: 2456245
[TBL] [Abstract][Full Text] [Related]
38. Report on a patient with watery diarrhoea syndrome caused by a pancreatic tumour containing neurotensin, enkephalin and calcitonin.
Gutniak M; Rosenqvist U; Grimelius L; Lundberg JM; Hökfelt T; Rökaeus A; Rosell S; Lundqvist G; Fahrenkrug J; Sundblad R; Gutniak E
Acta Med Scand; 1980; 208(1-2):95-100. PubMed ID: 7001860
[TBL] [Abstract][Full Text] [Related]
39. Distribution of vasoactive intestinal polypeptide-like immunoreactivity in the mammalian heart. Interrelation with neurotensin- and substance P-like immunoreactive nerves.
Weihe E; Reinecke M; Forssmann WG
Cell Tissue Res; 1984; 236(3):527-40. PubMed ID: 6205761
[TBL] [Abstract][Full Text] [Related]
40. Hypoglycemia-induced autonomic failure in IDDM is specific for stimulus of hypoglycemia and is not attributable to prior autonomic activation.
Rattarasarn C; Dagogo-Jack S; Zachwieja JJ; Cryer PE
Diabetes; 1994 Jun; 43(6):809-18. PubMed ID: 8194668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
